| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.27804 |
| P698 | PubMed publication ID | 25808625 |
| P2093 | author name string | Jae Sung Lee | |
| Su-Yeon Lee | |||
| Bo-Rahm Kim | |||
| Cheol Soo Choi | |||
| Hui-Young Lee | |||
| Bo-Kyung Kim | |||
| Tae-Sik Park | |||
| Soon-Mi Shim | |||
| In-Kyung Hong | |||
| P2860 | cites work | A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response | Q24305069 |
| Endoplasmic reticulum stress and the inflammatory basis of metabolic disease | Q24633352 | ||
| Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance | Q28291556 | ||
| Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent | Q28486289 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation | Q28510062 | ||
| The mammalian unfolded protein response | Q29547400 | ||
| Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 | ||
| Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells | Q33916859 | ||
| ER stress response: getting the UPR hand on misfolded proteins | Q33970911 | ||
| Reducing plasma membrane sphingomyelin increases insulin sensitivity | Q34208250 | ||
| Enzymes of sphingolipid metabolism: from modular to integrative signaling | Q34220989 | ||
| Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases | Q34234281 | ||
| Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
| Orchestrating the unfolded protein response in health and disease | Q35001604 | ||
| Sphingosine kinase, sphingosine-1-phosphate, and apoptosis | Q35047178 | ||
| Lipid overload and overflow: metabolic trauma and the metabolic syndrome | Q35568995 | ||
| Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction | Q36002934 | ||
| Endoplasmic reticulum stress in liver disease | Q36031838 | ||
| Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. | Q36366205 | ||
| Sphingosine kinase: biochemical and cellular regulation and role in disease | Q36439269 | ||
| Lipotoxic heart disease in obese rats: implications for human obesity | Q37117677 | ||
| Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2 | Q37622629 | ||
| Sphingolipids and insulin resistance: the five Ws. | Q37705954 | ||
| Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients? | Q37724503 | ||
| A protocol for rapid generation of recombinant adenoviruses using the AdEasy system | Q40124490 | ||
| Sphingosine kinase 1 participates in insulin signalling and regulates glucose metabolism and homeostasis in KK/Ay diabetic mice | Q40177082 | ||
| Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption | Q41119321 | ||
| The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis | Q41791624 | ||
| Endoplasmic reticulum stress promotes LIPIN2-dependent hepatic insulin resistance | Q41889666 | ||
| SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism | Q42810891 | ||
| Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes | Q42834541 | ||
| HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study | Q43247373 | ||
| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
| Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice | Q45151835 | ||
| TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes | Q46835510 | ||
| Mouse sphingosine kinase isoforms SPHK1a and SPHK1b differ in enzymatic traits including stability, localization, modification, and oligomerization | Q46861688 | ||
| Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention | Q56970669 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| insulin resistance | Q1053470 | ||
| steatosis | Q1365091 | ||
| P304 | page(s) | 135-146 | |
| P577 | publication date | 2015-04-22 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice. | |
| P478 | volume | 62 |
| Q92602255 | A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption |
| Q57128749 | Bile acids as global regulators of hepatic nutrient metabolism |
| Q33649252 | Celecoxib-mediated activation of endoplasmic reticulum stress induces de novo ceramide biosynthesis and apoptosis in hepatoma HepG2 cells mobilization. |
| Q52671501 | Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. |
| Q41573763 | Endoplasmic Reticulum Stress Inducer Tunicamycin Alters Hepatic Energy Homeostasis in Mice |
| Q91826367 | Fermented Cordyceps militaris Extract Prevents Hepatosteatosis and Adipocyte Hypertrophy in High Fat Diet-Fed Mice |
| Q37611624 | Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance |
| Q35965044 | Hydrophobic bile acid apoptosis is regulated by sphingosine-1-phosphate receptor 2 in rat hepatocytes and human hepatocellular carcinoma cells |
| Q90219783 | Lipid mediators of insulin signaling in diabetic kidney disease |
| Q38705659 | Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies |
| Q45324746 | RNAi screen reveals a role of SPHK2 in dengue virus-mediated apoptosis in hepatic cell lines |
| Q91892215 | SPHK1 deficiency protects mice from acetaminophen-induced ER stress and mitochondrial permeability transition |
| Q26773230 | Sphingolipids in High Fat Diet and Obesity-Related Diseases |
| Q45072762 | Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism. |
| Q41279386 | Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress. |
| Q39376014 | Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology |
| Q91666473 | Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation |
| Q92279683 | Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases |
| Q37024780 | The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities |
| Q37711953 | The role of sphingolipid signalling in diabetes‑associated pathologies (Review). |
| Q90024070 | The role of sphingosine kinase 2 in alcoholic liver disease |
| Q38909010 | The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. |
| Q91364063 | Tumor Microenvironment Regulation by the Endoplasmic Reticulum Stress Transmission Mediator Golgi Protein 73 in Mice |
| Q42370433 | Tumor necrosis factor-inducible gene 6 protein ameliorates chronic liver damage by promoting autophagy formation in mice. |
| Q92818439 | WITHDRAWN: Ceramide and Sphingosine 1-Phosphate in adipose dysfunction |
Search more.